Patent ID: 9702007
Date: 2017-07-11
CPC Classifications: A61K,A61P,C12Q

Claim:
1. A method for treating a human subject afflicted with multiple sclerosis or a single clinical attack consistent with multiple sclerosis with a pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier, comprising the steps of: (i) determining a genotype of the subject at single nucleotide polymorphism (SNP) kgp8817856; (ii) identifying the subject as a predicted responder to glatiramer acetate if the genotype of the subject contains one or more G alleles at the location of kgp8817856; and (iii) administering the pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier to the subject only if the subject is identified as a predicted responder to glatiramer acetate.